- Home
- ASYS vs CNTX Comparison
ASYS vs CNTX Comparison
Compare ASYS & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- CNTX
- Stock Information
- Founded
- ASYS 1981
- CNTX 2015
- Country
- ASYS United States
- CNTX United States
- Employees
- ASYS N/A
- CNTX N/A
- Industry
- ASYS Industrial Machinery/Components
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- CNTX Health Care
- Exchange
- ASYS Nasdaq
- CNTX Nasdaq
- Market Cap
- ASYS 83.0M
- CNTX 75.6M
- IPO Year
- ASYS N/A
- CNTX 2021
- Fundamental
- Price
- ASYS $9.24
- CNTX $0.84
- Analyst Decision
- ASYS
- CNTX Strong Buy
- Analyst Count
- ASYS 0
- CNTX 5
- Target Price
- ASYS N/A
- CNTX $5.25
- AVG Volume (30 Days)
- ASYS 295.9K
- CNTX 151.3K
- Earning Date
- ASYS 08-06-2025
- CNTX 11-05-2025
- Dividend Yield
- ASYS N/A
- CNTX N/A
- EPS Growth
- ASYS N/A
- CNTX N/A
- EPS
- ASYS N/A
- CNTX N/A
- Revenue
- ASYS $83,634,000.00
- CNTX N/A
- Revenue This Year
- ASYS N/A
- CNTX N/A
- Revenue Next Year
- ASYS $12.93
- CNTX N/A
- P/E Ratio
- ASYS N/A
- CNTX N/A
- Revenue Growth
- ASYS N/A
- CNTX N/A
- 52 Week Low
- ASYS $3.20
- CNTX $0.49
- 52 Week High
- ASYS $9.50
- CNTX $2.59
- Technical
- Relative Strength Index (RSI)
- ASYS 82.58
- CNTX 53.79
- Support Level
- ASYS $5.63
- CNTX $0.81
- Resistance Level
- ASYS $8.30
- CNTX $0.89
- Average True Range (ATR)
- ASYS 0.58
- CNTX 0.05
- MACD
- ASYS 0.29
- CNTX -0.01
- Stochastic Oscillator
- ASYS 93.28
- CNTX 25.00
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.